The White House on Tuesday pulled FDA Commissioner nominee Heidi Overton after GOP Senators derailed her confirmation.
President Trump in August announced the nomination of a new FDA Commissioner.
Trump nominated pro-MAHA Dr. Heidi Overton to replace Acting Commissioner Kyle Diamantas.
In May, Dr. Marty Makary resigned as FDA Commissioner.
Dr. Heidi Overton previously worked with RFK Jr and Dr. Oz to “deliver on the most transformative health agenda in history,” Trump said.
“Dr. Heidi has been a ROCKSTAR in my Administration, where she has worked directly with Secretary Kennedy, Dr. Oz, and team, to deliver on the MOST TRANSFORMATIVE Health Agenda in History,” Trump said in August in a Truth Social post.
“She is known to take on the HARDEST issues, and bring me solutions that work best for the Country. Heidi is “ALWAYS RIGHT,” Secretary Kennedy recently said in the Oval Office! We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES,” Trump said.
“Dr. Overton was a prestigious White House Fellow in my First Term, is a Board-Certified Physician in Public Health and General Preventive Medicine, and holds a Ph.D. in Clinical Investigations from the Johns Hopkins University. She is SMART and RESPECTED by all!” Trump said.
“Dr. Heidi will work with Secretary Kennedy and Dr. Oz to RAPIDLY deliver on my priorities of FASTER Cures, INCREASED American Innovation, MAJOR Clinical Trial Reforms, LOWER Drug Prices, and even more MAHA WINS!” Trump added.
On Tuesday evening, the White House pulled Heidi Overton’s nomination after GOP Senators refused to meet with her on the eve of a critical Senate panel vote.
The AP reported:
The White House said Tuesday it has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation.
Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for President Donald Trump or conservative groups aligned with his agenda. Her nomination in August was seen as a move to bring a stabilizing Trump loyalist to the FDA after a tumultuous year under Trump’s first FDA commissioner, Dr. Marty Makary.
But Overton faced bipartisan questions in the Senate about her willingness to break from Trump, particularly on his unsupported claims about the dangers of childhood vaccines.
Republican Sen. Bill Cassidy, a Louisiana doctor who chairs the Senate health committee, said earlier in the day he remained undecided about Overton ahead of a critical vote on her nomination scheduled for Wednesday.
Ad block users: Some site features may not work correctly while an ad blocker is enabled, because they break scripts and content this website depends on. If you can’t see comments below, for example, please disable your ad blocker.